SG Americas Securities’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
68,705
+15,218
| +28% | +$548K | 0.01% | 616 |
|
|
2025
Q1 | $1.67M | Buy |
+53,487
| New | +$1.67M | 0.01% | 785 |
|
|
2024
Q4 | – | Sell |
-62,131
| Closed | -$1.76M | – | 3066 |
|
|
2024
Q3 | $1.76M | Buy |
62,131
+53,008
| +581% | +$1.5M | 0.01% | 636 |
|
|
2024
Q2 | $241K | Sell |
9,123
-88,380
| -91% | -$2.33M | ﹤0.01% | 1858 |
|
|
2024
Q1 | $2.96M | Buy |
+97,503
| New | +$2.96M | 0.01% | 686 |
|
|
2023
Q4 | – | Sell |
-5,300
| Closed | -$144K | – | 3013 |
|
|
2023
Q3 | $144K | Sell |
5,300
-18,344
| -78% | -$498K | ﹤0.01% | 2296 |
|
|
2023
Q2 | $727K | Buy |
23,644
+11,910
| +101% | +$366K | 0.01% | 1084 |
|
|
2023
Q1 | $423K | Buy |
+11,734
| New | +$423K | ﹤0.01% | 1688 |
|
|
2022
Q4 | – | Sell |
-16,437
| Closed | -$660K | – | 2938 |
|
|
2022
Q3 | $660K | Sell |
16,437
-3,114
| -16% | -$125K | 0.01% | 1128 |
|
|
2022
Q2 | $822K | Buy |
19,551
+1,455
| +8% | +$61.2K | 0.01% | 1328 |
|
|
2022
Q1 | $705K | Buy |
+18,096
| New | +$705K | 0.01% | 1478 |
|
|
2021
Q4 | – | Sell |
-25,983
| Closed | -$939K | – | 3300 |
|
|
2021
Q3 | $939K | Buy |
25,983
+14,509
| +126% | +$524K | ﹤0.01% | 1806 |
|
|
2021
Q2 | $470K | Sell |
11,474
-22,925
| -67% | -$939K | ﹤0.01% | 1782 |
|
|
2021
Q1 | $1.5M | Buy |
34,399
+21,305
| +163% | +$929K | 0.01% | 1125 |
|
|
2020
Q4 | $655K | Buy |
+13,094
| New | +$655K | ﹤0.01% | 1561 |
|